For example, in the sensitivity analysis, the CTNNB1 mutation prevalence for colorectal cancer increased from 4.8% to 10.8%, and for lung cancer increased from 2.3% to 8.8%. This evidence concerns the gene CTNNB1 and colorectal cancer.